Treatment options for PNET liver metastases: a systematic review
Abstract Background Pancreatic neuroendocrine tumors (PNETs) are rare pancreatic neoplasms. About 40–80% of patients with PNET are metastatic at presentation, usually involving the liver (40–93%). Liver metastasis represents the most significant prognostic factor. The aim of this study is to present...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-07-01
|
Series: | World Journal of Surgical Oncology |
Online Access: | http://link.springer.com/article/10.1186/s12957-018-1446-y |